Volume 14 Issue 3, March 2000

Review

Antisense therapeutics in chronic myeloid leukaemia: the promise, the progress and the problems

RE Clark
Review 07 Mar 2000
Advertisement

Top of page ⤴

Original Manuscript

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials

I Hann
A Vora
OB Eden
Original Manuscript 07 Mar 2000
Use of dual-color interphase FISH for the detection of inv(16) in acute myeloid leukemia at diagnosis, relapse and during follow-up: a study of 23 patients

M Mancini
M Cedrone
A Hagemeijer
Original Manuscript 07 Mar 2000
Effects of cranial radiation in children with high risk T cell acute lymphoblastic leukemia: a Pediatric Oncology Group report

JH Laver
JC Barredo
J Shuster
Original Manuscript 07 Mar 2000
In vivo treatment of mutant FLT3-transformed murine leukemia with a tyrosine kinase inhibitor

M Zhao
H Kiyoi
T Naoe
Original Manuscript 07 Mar 2000
In vitro cytotoxic effects of fludarabine (2-F-ara-A) in combination with commonly used antileukemic agents by isobologram analysis

Y Kano
M Akutsu
K Kon
Original Manuscript 07 Mar 2000
Interferon alfa as primary treatment of chronic myeloid leukemia: long-term follow-up of 71 patients observed in a single center

O Kloke
B Opalka
N Niederle
Original Manuscript 07 Mar 2000
HLA class I in acute promyelocytic leukemia (APL): possible correlation with clinical outcome

E Bolognesi
G Cimino
P Momigliano-Richiardi
Original Manuscript 07 Mar 2000
Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells

U Kordes
D Krappmann
C Scheidereit
Original Manuscript 07 Mar 2000
CD40 ligand upregulates expression of the IL-3 receptor and stimulates proliferation of B-lineage acute lymphoblastic leukemia cells in the presence of IL-3

M Zhou
L Gu
HW Findley
Original Manuscript 07 Mar 2000
Cytokine upregulation of the antigen presenting function of acute myeloid leukemia cells

MW Boyer
EK Waller
AM Yeager
Original Manuscript 07 Mar 2000
Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules

Z Berke
MH Andersen
JS Haurum
Original Manuscript 07 Mar 2000
Frequent deletions at 11q23 and 13q14 in B cell prolymphocytic leukemia (B-PLL)

D Lens
E Matutes
LJA Coignet
Original Manuscript 07 Mar 2000
Arsenic trioxide (As₂O₃)-induced apoptosis and differentiation in retinoic acid-resistant acute promyelocytic leukemia model in hGM-CSF-producing transgenic SCID mice

K Kinjo
M Kizaki
Y Ikeda
Original Manuscript 07 Mar 2000
FLI-1 is a suppressor of erythroid differentiation in human hematopoietic cells

M Athanasiou
G Mavrothalassitis
DG Blair
Original Manuscript 07 Mar 2000
Lack of CD95/FAS gene somatic mutations in extranodal, nodal and splenic marginal zone B cell lymphomas

F Bertoni
A Conconi
E Zucca
Original Manuscript 07 Mar 2000
MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies

K Tsuboi
S Iida
R Ueda
Original Manuscript 07 Mar 2000
Transplantation of syngenic bone marrow contaminated with NGFr-marked WEHI-3B cells: an improved model of leukemia relapse in mice

J García-Castro
JC Segovia
JA Bueren
Original Manuscript 07 Mar 2000

Top of page ⤴

Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia

Introduction

JM Rowe
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Novel mechanisms of drug resistance in leukemia

DD Ross
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Monoclonal antibodies to the myeloid stem cells: therapeutic implications of CMA-676, a humanized anti-CD33 antibody calicheamicin conjugate

ID Bernstein
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Treatment of relapsed and refractory acute myelogenous leukemia

EH Estey
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Treatment of acute myelogenous leukemia in older adults

JM Rowe
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
New agents for acute myelogenous leukemia

JA Zwiebel
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Differentiation therapy in acute myelogenous leukemia (non-APL)

S Waxman
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Is there a best transplant conditioning regimen for acute myeloid leukemia?

FR Appelbaum
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Transplantation of hematopoietic stem cells from alternate donors in acute myelogenous leukemia

C Anasetti
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Use of thrombopoietic growth factors in acute leukemia

K Kaushansky
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Advances in the treatment of graft-versus-host disease

GB Vogelsang
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Introduction to Janet D Rowley

E Beutler
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000
Molecular genetics in acute leukemia

JD Rowley
Monograph from the Acute Leukemia Forum 1999 on Advances and Controversies in the Therapy of Acute Myelogenous Leukemia 07 Mar 2000